Published January 10, 2021 | Version v1
Journal article Open

Protein encapsulation by electrospinning and electrospraying

  • 1. BIOFABICS, Rua Alfredo Allen 455, 4200-135 Porto, Portugal
  • 2. School of Engineering, Institute for Materials and Processes, The University of Edinburgh, Robert Stevenson Road, Edinburgh EH9 3FB, UK
  • 3. UCL School of Pharmacy, University College London, 29-39 Brunswick Square, London WC1N 1AX, UK

Description

Given the increasing interest in the use of peptide- and protein-based agents in therapeutic strategies, it is fundamental to develop delivery systems capable of preserving the biological activity of these molecules upon administration, and which can provide tuneable release profiles. Electrohydrodynamic (EHD) techniques, encompassing electrospinning and electrospraying, allow the generation of fibres and particles with high surface area-to-volume ratios, versatile architectures, and highly controllable release profiles. This review is focused on exploring the potential of different EHD methods (including blend, emulsion, and co /multi-axial electrospinning and electrospraying) for the development of peptide and protein delivery systems. An overview of the principles of each technique is first presented, followed by a survey of the literature on the encapsulation of enzymes, growth factors, antibodies, hormones, and vaccine antigens using EHD approaches. The possibility for localised delivery using stimuli-responsive systems is also explored. Finally, the advantages and challenges with each EHD method are summarised, and the necessary steps for clinical translation and scaled-up production of electrospun and electrosprayed protein delivery systems are discussed.

Notes

This project has received funding from the European Union's Horizon 2020 research and innovation programme under the Marie Skłodowska-Curie grant agreement no 824007. KD thanks the EPSRC for the award of a PhD studentship in the Centre for Doctoral Training in Advanced Therapeutics & Nanomedicines (EP/L01646X/1), and UA the MRC for the provision of Confidence in Concept Funding (MC_PC_17180).

Files

Moreira J Controlled Release 2021_1st page.pdf

Files (193.0 kB)

Name Size Download all
md5:f97545febce9ea154f1136838b03c3fa
193.0 kB Preview Download

Additional details

Funding

iP-OSTEO – Induced pluripotent stem cell seeded active osteochondral nanofibrous scaffolds 824007
European Commission